Liver cancer sufferers are being condemned to an early death by being denied a new drug on the Health Service, campaigners warn.
They criticised draft guidance that will effectively ban the drug sorafenib - which is routinely used in every other country where it is licensed.
Trials show the drug, which costs £36,000 a year, can increase survival by around six months for patients who have run out of options.

The Government’s rationing body, the National Institute for Health and Clinical Excellence (Nice) said the overall cost was ‘simply too high’ to justify the ‘benefit to patients’.
However, relatively few would be eligible for the treatment - around 700, or one in four of those diagnosed each year with primary liver cancer.

(Hat tip: Taranto.)

It’s all nonsense. Laura Bush actually had more.

As if the whole petty question mattered. But to those to whom it does matter, the question must be asked: If in fact Michele Obama has fewer attendants than Laura Bush did, does that mean Obama is a better president than George W.? No? Then what’s the point of raising the issue in the first place?